PDE5 inhibition ameliorates visceral adiposity targeting the miR-22 / SIRT1 pathway: evidence from the CECSID trial

9 July 2016 (09:30 - 09:40)
Organised by: Logo
Congress Presentation Part of: Dysfunctional adipocytes in cardiovascular biology Metabolism / Diabetes mellitus Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science